Company / Assets per Share
Edgewise Therapeutics, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5.37
FY2025
5-year range
$5.27 / $7.60
FY2021-FY2025
Trend
+1.9%
vs FY2024
Sector context
#142 of 210
Health Care
What the data says
At $5.37, Edgewise Therapeutics, Inc.'s assets per share ranks #142 of 210 in the Health Care sector. Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $5.37.
Based on SEC 10-K filings.
5.37 in FY2025 with a 5-year CAGR of -50.3%.
Remained stable around $5.37 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -50.3%
- 10-Year CAGR
- -
Sector benchmark
#142 of 210 in Health CareTop 68% of 210This company $5.37 Sector average $296.79
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 1.9% year-over-year.
- Ranks #142 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.37 | +1.9% |
| FY2024 | $5.27 | -1.3% |
| FY2023 | $5.34 | -22.1% |
| FY2022 | $6.85 | -9.9% |
| FY2021 | $7.60 | -95.7% |
| FY2020 | $177.45 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026